Genpact (G) Issues FY18 Earnings Guidance
Genpact (NYSE:G) updated its FY18 earnings guidance on Monday. The company provided EPS guidance of $1.70-1.74 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.77. The company issued revenue guidance of $2.93-3.00 billion, compared to the consensus revenue estimate of $2.92 billion.
Several equities research analysts recently commented on the stock. Robert W. Baird reissued a buy rating and set a $38.00 price objective on shares of Genpact in a research note on Friday, November 10th. Cantor Fitzgerald reaffirmed a buy rating and issued a $36.00 target price on shares of Genpact in a report on Wednesday, November 8th. Finally, Zacks Investment Research raised shares of Genpact from a sell rating to a hold rating and set a $35.00 target price for the company in a report on Friday, November 10th. Three equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The stock currently has an average rating of Buy and an average price target of $33.38.
Genpact (G) opened at $32.30 on Tuesday. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 0.77. The stock has a market cap of $6,167.71, a PE ratio of 23.41, a price-to-earnings-growth ratio of 1.98 and a beta of 0.57. Genpact has a twelve month low of $23.34 and a twelve month high of $34.79.
In other news, insider Arvinder Singh sold 22,690 shares of the business’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $33.95, for a total transaction of $770,325.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Piyush Mehta sold 12,500 shares of the business’s stock in a transaction that occurred on Monday, November 27th. The shares were sold at an average price of $32.00, for a total transaction of $400,000.00. Following the transaction, the senior vice president now directly owns 77,944 shares of the company’s stock, valued at $2,494,208. The disclosure for this sale can be found here. Insiders have sold 1,660,470 shares of company stock valued at $50,598,982 over the last three months. 1.41% of the stock is owned by corporate insiders.
A hedge fund recently raised its stake in Genpact stock. The Manufacturers Life Insurance Company raised its holdings in shares of Genpact Limited (NYSE:G) by 7.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,508 shares of the business services provider’s stock after buying an additional 455 shares during the period. The Manufacturers Life Insurance Company ‘s holdings in Genpact were worth $181,000 at the end of the most recent quarter. Institutional investors and hedge funds own 92.00% of the company’s stock.
WARNING: This piece of content was reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this piece of content on another site, it was illegally copied and reposted in violation of US and international copyright & trademark law. The legal version of this piece of content can be read at https://theolympiareport.com/2018/02/13/genpact-g-issues-fy18-earnings-guidance.html.
Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.